Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Medication Use Evaluation for Enoxaparin in Hospitalized COVID-19 Patients

NCT05226793 is registered in ClinicalTrials.gov with Methodist Health System as lead sponsor.

NCT NCT05226793
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05226793 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Medication Use Evaluation for Enoxaparin in Hospitalized COVID-19 Patients
Lead sponsor
Methodist Health System
Phase
Observational
Overall status
Completed
Start date
November 17, 2021
Completion date
July 22, 2025
Enrollment
400 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

venous thromboembolism